Skip to main content

Month: July 2021

Fortuna reports production of 55,953 gold equivalent ounces for the second quarter and issues updated guidance for 2021

VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) — Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports production results for the second quarter from its three operating mines in the Americas, the San Jose Mine in Mexico, the Caylloma Mine in Peru, and the Lindero Mine in Argentina. The company produced 1,892,822 ounces of silver and 31,048 ounces of gold or 55,953 gold equivalent1 ounces. Silver and gold production for the first six months of 2021 totaled 3,806,577 ounces and 65,603 ounces, respectively, or 115,690 gold equivalent1 ounces. The company is also providing an updated production and cost guidance for 2021 which also incorporates gold production for the second half of the year from the Yaramoko Mine in Burkina Faso. Second Quarter Consolidated ProductionSilver production of 1,892,822 ounces; 49 percent...

Continue reading

Give and Go Prepared Foods (U.S.A.) Corp. Conducts Voluntary Recall of Certain Muffin Products Due to Possible Health Risk

SHIRLEY, N.Y., July 19, 2021 (GLOBE NEWSWIRE) — Give and Go Prepared Foods (U.S.A.) Corp. announced today a voluntary nationwide recall of certain muffin products due to the potential for the products to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women. This recall is limited solely to the products listed below, which have been sold in retail stores nationwide. No other Give & Go products are affected, and this recall does not affect products in countries...

Continue reading

AgraFlora Announces Debt Settlement

VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) announces that its Board of Directors has approved the settlement of amounts owing for services rendered (the “Debt Settlement“) through the issuance of common shares (the “Shares”). Pursuant to the Debt Settlement, the Company issued an aggregate amount of 803,783 Shares at a deemed price of $0.05 per Share. All Shares issued will be subject to a minimum hold period of four months and one day from the date of issuance. About AgraFlora Organics International Inc. AgraFlora Organics International Inc. is a cannabis company building shareholder value through the development of revenue-generating, operated assets in the global cannabis industry....

Continue reading

Water Clarifiers Market to Reach USD 9.66 Billion on Account of Rising Need for Recycling Water Worldwide to Meet demands says Fortune Business Insights™

List of the Companies Profiled in the Market: CHENNAI EQUIPMENTS & SYSTEMS PVT LTD (India), Evoqua Water Technologies LLC (USA), Shri Rajhans Engineering Works (India), WesTech Engineering, Inc. (USA), Lakeside Equipment Corporation (USA), Hydro International UK Ltd (UK), Veolia Water Technologies (France), Parkson Corporation (USA), Kurita Water Industries Ltd. (Japan), Murugappa Organo Water Solutions Private Limited (MOWS) (India), Spacetech Equipments & Structurals Private Limited. (India), Feralco AB (Sweden), IXOM (Australia), SUEZ (France) Pune, India, July 19, 2021 (GLOBE NEWSWIRE) — The global water clarifiers market size is forecast to reach USD 9.66 billion by 2026, attributable to the increasing need to provide wastewater treatment worldwide. Governments of various nations launched stringent regulations on...

Continue reading

Chavant Capital Acquisition Corp. Announces Pricing of $80 Million Initial Public Offering

NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) — Chavant Capital Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 8,000,000 units at a price of $10.00 per unit. The units will be listed on The NASDAQ Capital Market (“NASDAQ”) and trade under the ticker symbol “CLAYU” beginning on July 20, 2021. Each unit consists of one ordinary share and three-quarters of one redeemable warrant, with each whole warrant exercisable to purchase one ordinary share at a price of $11.50 per share. After the securities comprising the units begin separate trading, the ordinary shares and warrants are expected to be listed on NASDAQ under the symbols “CLAY” and “CLAYW,” respectively. The offering is expected to close on July 22, 2021, subject to customary closing...

Continue reading

Brickell Biotech Increases Previously Announced Bought Deal Offering of Common Stock to $7.0 Million

BOULDER, Colo., July 19, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (Nasdaq: BBI) (the “Company” or “Brickell”), clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 11,290,323 shares of common stock of the Company at a price to the public of $0.62 per share, less underwriting discounts and commissions. The closing of the public offering is expected to occur on or about July 22, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The Company has granted...

Continue reading

The Becker Milk Company Limited: 2021 Annual Financial Results

TORONTO, July 19, 2021 (GLOBE NEWSWIRE) — The Becker Milk Company Limited (the “Company”) (TSX-BEK.B) is pleased to report the results for the year ended April 30, 2021. HIGHLIGHTSTotal revenues for the year ended April 30, 2021 were $3,097,155 compared to $3,174,164 for the same period in 2020; Net operating income for the year was $2,367,836 compared to $2,569,034 in 2020; Net income for the year was 1.96 per share, compared to 0.46 per share in 2020.FINANCIAL HIGHLIGHTS Net operating income for the year ended April 30, 2021 decreased $201,198 to $2,367,836 as compared with the previous year, as a result of reduced property revenue and higher property operating expenses.                         Year ended          April 30            2021       2020  Property revenue       $3,024,970     $3,036,785  Finance...

Continue reading

Bombardier Announces Redemption Price Calculation in Respect of its 5.750% Senior Notes Due 2022

MONTRÉAL, July 19, 2021 (GLOBE NEWSWIRE) — Pursuant to Bombardier Inc.’s (“Bombardier”) notice of redemption dated June 22, 2021 (the “Notice”) relating to all of its outstanding 5.750% Senior Notes due 2022 (the “Notes”), Bombardier today announced the calculation of the redemption price for the Notes. The redemption price for the Notes will be US$1,053.81 per US$1,000.00 principal amount of Notes, consisting of the Make-Whole Premium of US$1,033.53 per US$1,000.00 (based on a Treasury Rate of 0.054%, as calculated by Bombardier on July 19, 2021), plus US$20.28 in accrued and unpaid interest to but excluding the redemption date for the Notes, all as calculated in accordance with the terms of the indenture governing the Notes. The redemption date for the Notes is July 22, 2021, as set forth in the Notice. This press release does...

Continue reading

Junshi Biosciences and Immorna Announce Joint Venture to Develop Innovative Self-Replicating and Conventional mRNA Therapeutics and Vaccines

SHANGHAI, China, July 20, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the company has established a joint venture with Immorna, a fast-growing biotechnology company focusing on the process development and optimization of mRNA and delivery vehicles and the research and development of new nucleic acid drugs, to develop and commercialize new drugs for the global market in the fields of cancer, infectious diseases, rare diseases, and other diseases, based on the mRNA technology and other technology platforms. Immorna’s unique mRNA construction and established versatile process platform are suitable for the development of self-replicating mRNA as well as...

Continue reading

Daseke, Inc. to Release Second Quarter Results on August 3, 2021

ADDISON, Texas, July 19, 2021 (GLOBE NEWSWIRE) — Daseke, Inc. (NASDAQ: DSKE) (or the “Company”), the largest flatbed, specialized transportation and logistics solutions company in North America, today announced that it plans to report results for its fiscal second quarter ended June 30, 2021 on August 3, 2021. A conference call to discuss the financial and operational results is scheduled for August 3, 2021 at 11:00 AM ET. Investors, analysts, and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides, available on the Company’s website at https://www.daseke.com. Interested parties may also participate in the call by dialing (855) 242-9918 and entering the passcode 1980152. A replay of the conference call will be available a few hours...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.